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Abstract
Objectives To determine if quantitative and qualitative shear
wave elastography have roles in evaluating musculoskeletal
masses.
Methods 105 consecutive patients, prospectively referred for
biopsy within a specialist sarcoma centre, underwent B-mode,
quantitative (m/s) and qualitative (colour map) shear wave
elastography. Reference was histology from subsequent
biopsy or excision where possible. Statistical modelling was
performed to test elastography data and/or B-mode imaging in
predicting malignancy.
Results Of 105 masses, 39 were malignant and 6 had no his-
tology but benign characteristics at 12 months. Radiologist
agreement for B-mode and elastography was moderate to
excellent Kw 0.52-0.64; PABAKw 0.85-0.90). B-Mode
imaging had 78.8% specificity, 76.9% sensitivity for malig-
nancy. Quantitatively, adjusting for age, B-mode and lesion
volume there was no statistically significant association
between longitudinal velocity and malignancy (OR [95%
CI] 0.40[0.10, 1.60], p=0.193), but some evidence that higher
transverse velocity was associated with decreased odds of
malignancy (0.28[0.06, 1.28], p=0.101). Qualitatively malig-
nant masses tended to be towards the blue spectrum (lower
velocities); 39.5% (17/43) of predominantly blue masses were
malignant, compared to 14.3% (1/7) of red lesions.
Conclusions Quantitatively and qualitatively there is no
statistically significant association between shear wave
velocity and malignancy. There is no clear additional role to
B-mode imaging currently.
Key Points
• Correlation between shear wave velocity and soft tissue
malignancy was statistically insignificant
• B-mode ultrasound is 76.9 % sensitive and 78.8 % specific
• Statistical models show elastography does not significantly
add to lesion assessment
Keywords Ultrasound . Sarcoma . Imaging . Elasticity
imaging techniques . Soft tissue neoplasms
Introduction
Soft tissue sarcomas constitute less than 1 % of all malignan-
cies. [1] Soft tissue masses have a benign to malignant ratio of
over 100:1 [2, 3], meaning that a large number of lesions that
are ultimately benign will undergo imaging investigation and
biopsy.
Elastography uses external compression to determine tissue
strain and lesion stiffness [4]. The more recent development of
acoustic radiation force impulse (ARFI) imaging does not
require operator external compression, and thus should give
less variability. Soft tissues are transiently deformed using
acoustic radiation and the measured dynamic displacement
is used to estimate the tissue's mechanical properties. [5] It
has been established that benign breast and prostate masses
tend to be soft and malignant masses tend to be stiff. [6] In
breast imaging, elastography has been shown to improve
specificity [7] and potentially further characterise B-mode-
detected breast lesions [8] with highly reproducible results [9].
In musculoskeletal imaging, ultrasound (US) is well
established as a diagnostic tool [10, 11] for initially assessing
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clinically suspicious soft tissue masses [12]. The role of shear
wave elastography inmusculoskeletal imaging has been large-
ly limited to the evaluation of tendon disorders [13–15].
There is only limited published data on the role of
sonoelastography in the evaluation of soft tissue masses [16,
17]. The aim of this study was to determine whether quanti-
tative and qualitative shear wave elastography when assessed
along with B-mode US imaging could have a role in the eval-
uation of musculoskeletal soft tissue masses.
Materials and methods
Patient population
The institutional ethics committee approved the study proto-
col and all patients underwent informed consent. Consecutive
patients were prospectively referred from the specialist sarco-
ma service over a nine-month period for soft tissue biopsy of
an extremity soft tissue mass with no clinical exclusion
criteria.
B-Mode US imaging
All B-mode imaging was performed by one of three experi-
enced consultant musculoskeletal radiologists (15, six, and four
years experience) using US (Siemens Acuson S3000,
Erlangen, Germany) and a linear array transducer (9-4 MHz).
B-mode US findings (echogenicity compared to muscle,
homogenous vs heterogeneous), lesion size (3 dimensions,
cm), vascularity (power Doppler recorded as absent, present
linear or present disorganised) and lesion position (subcutane-
ous, deep intramuscular or deep intermuscular) were docu-
mented for all patients.
At a subsequent sitting over 1 month following the initial
study, the anonymised B-mode images were reviewed inde-
pendently by the three radiologists blinded to the other forms
of imaging, elastography, and histology. The B-mode images
were subjectively classified, using previously described B-
mode criteria [12] into a four-point system assessing the like-
lihood of the lesion being benign or malignant; 1=definite
benign, 2 = indeterminate benign, 3 = indeterminate malig-
nant, 4 = definite malignant. Discrepancies between scores
were then resolved by consensus.
SW Elastographic imaging
Prior to biopsy all patients underwent acoustic radiation force
impulse (ARFI) imaging (Virtual Touch Quantification;
Siemens) where shear waves are generated after the applica-
tion of the focused push pulse while holding the probe lightly
on the skin surface and the adjacent muscles are relaxed [18,
19]. The user defined a region of interest (ROI) and the
software synthesised information from 256 sequential acqui-
sition beam lines to generate qualitative and quantitative shear
wave velocitymapswith the velocity range kept constant at 0 -
10 metres per second (m/s) [18]. Initially, a quality map was
produced displaying the quality range of the readings with
green representing good quality and red meaning bad quality
(Fig. 1). Shear wave velocity colour maps in both longitudinal
Fig. 1 Glomus tumour in a 62-year-old patient. (a) Transverse B-mode
image shows an oval mass with solid vascular periphery and necrotic/
cystic centre. (b) Corresponding shear wave velocity quality mapwith the
solid area green (good quality reading) (solid arrow) and cystic/necrotic
area red (poor quality reading)(hollow arrow). (c) Corresponding shear
wave qualitative map, which is predominantly blue/cyan with five
quantitative readings
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and transverse planes were obtained and five quantitative
readings taken using 2 × 2 mm ROIs in the most
homogenously solid (and vascular when present) area of the
mass, which demonstrated good quality readings on the ac-
companying quality map. The mean of the five velocity read-
ings was used for further statistical analysis. In 28 patients,
colour maps and velocity readings were repeated independent-
ly by a second operator blinded to the initial readings to allow
inter-observer assessment.
The anonymised colour shear wave velocity maps were
evaluated with colour percentage image processing software
(Image J analysis in Java, National Institute of Health)
documenting five categories: red (high velocity), orange/yel-
low, yellow/green, cyan and blue (lowest velocities) relating
to the dominant distribution of shear wave elastography read-
ings. Any areas within the map returning no colour (e.g. cystic
or necrotic areas) were not included in the software analysis.
Masses subsequently underwent percutaneous biopsy, ex-
cision, or both, and histological diagnosis (and where appro-
priate molecular and cytogenetic analysis) was taken as the
reference standard.
Statistical analysis
Based on pilot study data, we anticipated that 30 % of lesions
would be malignant. Assuming that we wished to control for
up to four independent variables in a logistic regression mod-
el, to satisfy rules of thumb requiring 10 events per variable,
the study designed required n=135 patients to be recruited
[20].
For lesions that were located both subcutaneously and ex-
tending into deep tissues, if any part of the lesion extended
into the muscle, it was coded intramuscular (n=3), otherwise
it was coded intermuscular (n=1). Mass volume was calcu-
lated assuming an ellipsoid shape as π/6 x craniocaudal
(hereafter longitudinal) x anteroposterior x transverse. Prior
to statistical analysis, right-skewed continuous variables
(shearwave velocity and lesion volume) were natural log-
transformed. Shearwave colour map data (proportions of
pixels that were red, orange, yellow, cyan, or blue) were used
to determine the dominant colour of the lesion. Intra-reader
reliability of velocity measurements was assessed using
intraclass correlation coefficients (ICCs); agreement over B-
mode classification and dominant lesion colour were assessed
using quadratic-weighted Kappa (Kw), prevalence-adjusted
bias-adjusted quadratic-weighted Kappa (PABAKw), and
proportions of positive agreement. Spearman’s rho coeffi-
cients were calculated to assess associations among map col-
our proportions and mean shearwave velocities; Pearson’s r
coefficients were calculated for associations among ln-
transformed shear wave velocities and volume. Analysis of
variance (ANOVA) was used to test the extent to which the
dominant map colour was associated with shearwave velocity.
Kruskal-Wallis test was used to compare the ratio of
longitudinal:transverse velocity between lesions located with-
in muscles, between muscles, or solely in subcutaneous tissue.
Linear regression was used to model associations between B-
mode findings and shear wave velocity. Binary logistic regres-
sion was used to determine the unadjusted and adjusted odds
of malignancy based on the B-mode findings and shear wave
velocities, adjusted for demographic variables. Appropriate
checks were made that test assumptions were met. The four
B-mode consensus categories were collapsed into ‘definitely
or indeterminately benign’ and ‘definitely or indeterminately
malignant’ to calculate sensitivity and specificity. Pseudo R-
squared and Akaike’s Information Criterion (AIC) were cal-
culated to compare the predictive strengths of different
models. Bootstrapping using 2000 replicates was used to ob-
tain stable standard error estimates for regression coefficients.
All analyses were conducted in Stata 13.1 (StataCorp.
2013. Stata Statistical Software: Release 13. College
Station,TX).
Results
The original recruitment target was n=135; however, due to
limited equipment availability, n=114 patients were recruited.
Of these 114 patients, nine did not have shear wave measure-
ments available and were excluded from analysis. Of the re-
maining 105 patients, in six cases no biopsy was performed
because of patient choice (n=5) or technically difficult biopsy
(n=1). All had benign imaging appearances and the lesions
were assumed to be benign for the purposes of analysis,
since at follow-up imaging (12 months) all lesions had
remained unchanged (n=5) or resolved (n=1, haematoma).
Demographic characteristics and US findings for the 105 pa-
tients are summarised in Table 1. Although this fell short of
the intended sample size of 135, with 39 malignant lesions the
event-per-variable ratio was still approximately 10:1 in our
multivariable logistic regression models of malignancy, which
contained up to four variables. Biopsy confirmed malignant
lesions in 39 (37.1 %).
Reliability of US classification
Radiologist agreement for US diagnosis was moderate,
but was excellent when the effects of prevalence and bias
were taken into account (Kw 0.52-0.64; PABAKw 0.85-
0.90). Compared to the eventual consensus classification,
for each individual reader the agreement was substantial
(Kw = 0.74-0.82) and each reader over- and under-
estimated the consensus classification in no more than
16 % of cases in each direction.
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Associations between B-mode findings and consensus
classification
A binary logistic regression model of the individual US find-
ings, in which the collapsed consensus classification (benign
vs malignant) was the outcome, showed that the odds of a
lesion being classified as indeterminate malignant or malig-
nant were not substantively associated with lesion heteroge-
neity or lesion position (Table 2). The odds were substantively
higher for necrotic masses, although not statistically signifi-
cant. Hyperechogenic lesions were less likely to be considered
malignant, whilst the odds were slightly raised for linear and
raised considerably for lesions with a disorganised power
Doppler signal.
Sensitivity and specificity of consensus 2D scoring
for malignancy
After collapsing the four consensus categories, sensitivity
(Wilson 95%CI) was 76.9% (61.7%, 87.4%) and specificity
was 78.8 % (67.5 %, 86.9 %) (Table 3). However, 9/39 ma-
lignant masses (23.1 %) were classified as definitely or inde-
terminately benign on the 2D consensus score (n=8 low grade
sarcomas, n=1 high grade pleomorphic sarcoma) (Fig. 2).
Reliability of shear wave velocity measurements
The shear wave readings repeated in 28 patients suggested
they were highly reproducible (longitudinal ICC [95 % CI]
0.89 [0.79, 0.95]; transverse 0.98 [0.96, 0.99]). The ICCs for
average values from two readers were 0.94 (0.88, 0.97) and
0.99 (0.98, 1.00), respectively.
Reliability of shear wave colour map measurements
Repeated colour map measurements were available for n=26
patients (missing in two cases due to a data fault). Agreement
for predominant colour map proportions was substantial in
both planes (Kw [95 % CI] longitudinal 0.84 [0.56, 0.96];
transverse 0.81 [0.58, 0.94]).
Patterns in the data with respect to shear wave velocity
Longitudinal and transverse shear wave velocity measurements
were strongly correlated (n=105, Pearson’s r=0.91, p<0.001;
Fig. 3). There was a weak negative correlation between shear
wave velocity and lesion volume (longitudinal r = -0.30,
p=0.001; transverse r= -0.29, p=0.003; Fig. 4). In this unad-
justed analysis, there was no evidence to suggest that velocity
in either plane varied with patient age (data not shown).
Using shear wave velocities as the outcomes in multiple
linear regression models, controlling for homogeneity, necro-
sis, echogenicity, power Doppler signal, lesion volume, and
position revealed that longitudinal velocity tended to be higher
in necrotic and/or heterogeneous lesions (Table 4). Having
controlled for the US findings, there was around a 1 % de-
crease in velocity for every 10 % increase in lesion volume.
Hyperechogenicity, doppler signal, and lesion position were
not associated with longitudinal velocity. Results were similar
in the transverse plane, but necrosis and heterogeneity were
not significant even at the 10 % level.
Table 1 Demographic characteristics and US findings in patients with
shear wave velocity measurements available (n = 105)
Continuous variable All patients (n = 105)
Age, years
Mean (SD) 52.3 (18.3)
Range 20 to 88
Sex
Male % (n) 54.3 % (57)
Longitudinal SW velocity, m/s
Geometric mean 2.80
Median (IQR) 2.54 (1.94, 4.12)
Range 0.82 to 9.65
Longitudinal SW colour
Red 7.7 % (7/91)
Orange - (0/91)
Yellow 30.8 % (28/91)
Cyan 14.3 % (13/91)
Blue 47.3 % (43/91)
Transverse SW velocity, m/s
Geometric mean 2.79
Median (IQR) 2.42 (1.94, 4.30)
Range 1.01 to 9.78
Transverse SW colour
Red 10.8 % (10/93)
Orange - (0/93)
Yellow 29.0 % (27/93)
Cyan 7.5 % (7/93)
Blue 52.7 % (49/93)
Mass volume, cm3
Geometric mean 29.2
Median (IQR) 24.90 (10.08, 92.36)
Range 0.20 to 3247.43
Lesion position
Subcutaneous only % (n) 28.6 % (30)
Deep % (n) 71.4 % (75)
Inter-muscular % (n) 35.2 % (37)
Intra-muscular % (n) 36.2 % (38)
Mass quality
Heterogeneous % (n) 65.7 % (69)
Necrotic % (n) 28.6 % (30)
Echogenicity
Hyperechogenic % (n) 8.6 % (9)
Power Doppler signal
Present % (n) 61.0 % (64)
Linear % (n) 24.8 % (26)
Disorganised % (n) 35.2 % (37)
Mixed % (n) 1.0 % (1)
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Mass location and velocity
There were no substantive differences between lesions located
subcutaneously, between or within muscles, in either plane
(longitudinal ANOVA F(2,102) = 1.24, p = 0.294; transverse
F=1.03, p=0.360).
Expressing velocity in the two planes as a ratio
(longitudinal:transverse) revealed that intramuscular masses
tended to have faster longitudinal velocity relative to transverse
velocity, while for lesions located elsewhere the velocities were
more evenly balanced (intramuscular n=38, median (inter-
quartile range) 1.05 [0.97, 1.13]; subcutaneous n=30, 1.00
[0.90, 1.13]; intermuscular n=37 0.98 [0.86, 1.09]). However,
overall there was not a statistically significant difference be-
tween the three groups (Kruskal-Wallis X2(2)=2.34, p=0.311).
Shear wave velocity, US findings, and diagnosis
Mean colour map pixel proportions showed a tendency for
malignant masses to be towards the blue spectrum.
However, the proportion of malignant lesions did not differ
substantively between those that were predominantly blue
(39.5 % [17/43]), cyan (46.2 % [6/13]) or yellow (42.9 %
[12/28]). A smaller proportion of red lesions were malignant
(14.3 % [1/7]); however, sample size was very small for this
category, which means this estimate is likely to be inaccurate.
Binary logistic regression models were constructed to exam-
ine whether shear wave velocity provided additional predictive
power for detection of biopsy-confirmed malignancy over and
above B-mode consensus classification. Longitudinal and trans-
verse velocities were not entered into the same model to avoid
problems of multicollinearity. Instead, each was entered into a
separate multivariable model (Table 5). In simple (unadjusted)
analyses, older age, malignant consensus US diagnosis and
greater lesion volume were all associated with significantly
higher odds of confirmed malignancy. Shear wave velocities
were substantively lower in malignant lesions (geometric mean
m/s longitudinal benign 2.94 vs. malignant 2.57; transverse 2.93
vs. 2.56). However, the confidence intervals around the associ-
ated odds ratios were wide and crossed 1. In the first of the
adjusted models (model 1) only age, US consensus classifica-
tion and lesion volume were entered. In this model, a B-mode
consensus classification of definitely or indeterminately malig-
nant was significantly associated with higher odds of confirmed
malignancy, with evidence (borderline-significant at 10% level)
Table 2 Associations between
US findings and collapsed





US characteristic Collapsed consensus classification Odds ratio1 (95 % CI) P value
Benign Malignant
Mass texture
Homogeneous 72.2 % (26) 27.8 % (10) Reference
Heterogeneous 50.7 % (35) 49.3 % (34) 1.20 (0.33, 4.36) 0.777
Necrosis
Absent 65.3 % (49) 34.7 % (26) Reference
Present 40.0 % (12) 60.0 % (18) 1.63 (0.41, 6.42) 0.488
Echogenicity
Hypo or mixed 55.2 % (53) 44.8 % (43) Reference
Hyper 88.9 % (8) 11.1 % (1) 0.20 (0.05, 0.82) 0.025
Power Doppler
Absent 80.5 % (33) 19.5 % (8) Reference
Linear 59.3 % (16) 40.7 % (11) 2.19 (0.53, 9.09) 0.282
Disorganised 32.4 % (12) 67.6 % (25) 7.79 (1.90, 31.94) 0.004
Position
Subcutaneous 56.7 % (17) 43.3 % (13) Reference
Intermuscular 51.4 % (19) 48.7 % (18) 1.11 (0.27, 4.49) 0.883
Intramuscular 65.8 % (25) 34.2 % (13) 0.57 (0.12, 2.82) 0.492
1 From multivariable logistic regression model including all US characteristics
Table 3 Proportions of masses found to be benign or malignant
according to the results of 2-D consensus scoring






Definitely benign 7.6 % (5) 2.6 % (1)
Indeterminate (benign) 71.2 % (47) 20.5 % (8)
Indeterminate (malignant) 21.2 % (14) 53.9 % (21)
Malignant - (0) 23.1 % (9)
Benign (2-D score 1 or 2) 78.8 % (52) 23.1 % (9)
Malignant (2-D score 3 or 4) 21.2 % (14) 76.9 % (30)
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that greater volume and older age were associated with in-
creased odds of malignancy. Adding in longitudinal shear wave
velocity (model 2) improved the model performance in terms of
pseudo R-squared and AIC very slightly, but again no statisti-
cally significant association between velocity and malignancy
was found, despite the odds ratio (OR) being lower in this ad-
justed model compared to the unadjusted OR. In model 3 there
was some evidence (borderline-significant at 10 % significance
level) that higher transverse velocity was associated with de-
creased odds of malignancy.
Using the predicted probabilities from each model, the area
under the receiver operating characteristic curve (AUC ROC)
was calculated for eachmodel. There was very little difference
between the three models, indicating that adding shear wave
velocity in either plane did little to improve the predictive
strength of the model.
Fig. 2 Liposarcoma grade 1 in a 79-year-old patient. (a) Longitudinal
B-mode panoramic image showing well-demarcated subfascial
intramuscular lipomatous lesion (solid arrows). (b) Corresponding shear
wave qualitative map, which is predominantly blue/cyan with five
quantitative readings performed in transverse plane on small area of the
superficial aspect of the lesion
Fig. 3 Association between shear wave velocities in the longitudinal and
transverse planes (n = 105)
Fig. 4 Associations between lesion volume and shear wave velocities in
the longitudinal and transverse planes (n = 105)
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Adding shear wave velocities to models that included US
consensus classification did not substantively improve diag-
nostic accuracy. We investigated models which included age,
lesion volume, and shear wave velocity. However, in these
models shear wave velocity was neither substantively nor sig-
nificantly associated with malignancy (longitudinal OR [95 %
CI] 0.99 [0.36, 2.71]; transverse 0.85 [0.30, 2.41]) and predic-
tive ability was reduced (ROC [95 % CI] longitudinal 0.77
[0.67, 0.86]; transverse 0.77 [0.68, 0.87]) compared to model
1 (Table 5).
In model 1, which included age and lesion volume in
addition to B-mode consensus classification but did not
include shear wave velocity, AUC ROC was high at 0.87
(0.79, 0.95). Choosing a cut-point with a maximal Youden
Index ([sensitivity+ specificity]-1), i.e. the point at which
misclassifications were minimized, yielded a sensitivity of
74 % (95 % CI 59 %, 85 %) and specificity of 91 %
(82 %, 96 %). Compared to the consensus classification
alone, the sensitivity was similar (cf 77 %) and the speci-
ficity was improved (cf 79 %); this difference was statisti-
cally significant (Chi-square(2) = 8.20, p = 0.017). In this
sample, negative predictive value was similar whether con-
sensus scoring was used alone (85 %) or in combination
with age and lesion volume (86 %) but with the addition of
Table 4 Adjusted associations
between US findings and shear
wave velocities in the
longitudinal and transverse planes
Ratio (95 % CI), P value
Longitudinal Transverse
Heterogeneous vs homogenenous 1.20 (0.96, 1.50), p = 0.101 1.13 (0.89, 1.44), p = 0.318
Necrotic vs non-necrotic 1.25 (1.02, 1.54), p = 0.043 1.13 (0.92, 1.39), p = 0.238
Hyperechogenic vs hypo/mixed 0.85 (0.67, 1.07), p = 0.169 0.94 (0.70, 1.25), p = 0.659
PD linear vs PD absent 1.18 (0.93, 1.48), p = 0.169 1.20 (0.93, 1.55), p = 0.153
PD disorg vs PD absent 1.06 (0.85, 1.32), p = 0.597 1.11 (0.89, 1.40), p = 0.361
Lesion volume -0.93 (-1.43, -0.43)*, p < 0.001 -0.82 (-1.37, -0.27)*, p = 0.004
Intramuscular vs subcutaneous 0.89 (0.71, 1.11), p = 0.293 0.92 (0.73, 1.16), p = 0.475
Intermuscular vs subcutaneous 0.89 (0.70, 1.14), p = 0.374 0.88 (0.69, 1.13), p = 0.330
*Expected % decrease in velocity per 10 % increase in volume
Table 5 Odds of confirmed malignancy according to US consensus classification, lesion volume, and shear wave velocity
Biopsy confirmed
diagnosis












Per year 48.1 (17.5) 59.3 (17.7) 1.04 (1.01, 1.06) 1.03 (1.00, 1.06), p = 0.091 1.03 (0.99, 1.07), p = 0.110 1.03 (0.99, 1.07), p = 0.097
US consensus
Benign 78.8 % (52) 23.1 % (9) Reference Reference Reference Reference
Malignant 21.2 % (14) 76.9 % (30) 12.38 (4.55, 33.72) 12.38 (2.75, 55.76), p = 0.001 17.11 (2.94, 99.62), p = 0.002 19.59 (3.31, 116.01), p = 0.001
Lesion volume
per ln(cm3) 2.80 (1.68) 4.35 (1.86) 1.68 (1.18, 2.40) 1.52 (0.92, 2.53), p = 0.105 1.38 (0.82, 2.30), p = 0.224 1.33 (0.79, 2.23), p = 0.285
Longitudinal SW velocity
per ln(m/s) 1.08 (0.49) 0.95 (0.54) 0.60 (0.25, 1.40) - 0.40 (0.10, 1.60), p = 0.193 -
Transverse SW velocity
per ln(m/s) 1.07 (0.51) 0.94 (0.46) 0.57 (0.25, 1.29) - - 0.28 (0.06, 1.28), p = 0.101
Model performance indictors
Pseudo R-squared 0.35 0.37 0.38
Akaike Information Criterion 98.39 97.78 96.3
Area under ROC curve (95 % CI) 0.87 (0.79, 0.95) 0.87 (0.80, 0.95) 0.88 (0.80, 0.95)
Maximum YI 0.65 0.67 0.67
Predicted probability at max YI 0.53 0.53 0.42
Sensitivity at max YI (95 % CI) 0.74 (0.59, 0.85) 0.74 (0.59, 0.85) 0.79 (0.64, 0.89)
Specificity at max YI (95 % CI) 0.91 (0.82, 0.96) 0.92 (0.83, 0.97) 0.88 (0.78, 0.94)
PPVat max YI (95 % CI) 0.83 (0.67, 0.92) 0.85 (0.70, 0.94) 0.79 (0.64, 0.89)
NPVat max YI (95 % CI) 0.86 (0.76, 0.92) 0.86 (0.76, 0.92) 0.88 (0.78, 0.94)
NPV = negative predictive value; OR = odds ratio; PPV = positive predictive value; ROC = receiver operating characteristic curve for predicted
probability; SW = shear wave; YI = Youden Index ([sensitivity + specificity]-1)
Eur Radiol (2017) 27:723–731 729
these variables, positive predictive value increased from 68
to 83 %.
Discussion
Conventional imaging cannot always differentiate between
malignant and benign lesions, meaning that biopsy is required
to establish a diagnosis and guide management [21, 22]. The
consensus B-mode US scoring demonstrated sensitivity and
specificity of 76.9 and 78.8 %, confirming that it is not suffi-
ciently accurate to be used alone in providing this differentia-
tion, although this was under study conditions where scorers
were blinded to the history and any other imaging performed.
In this study, nine masses scored as benign or indeterminately
benign on B-mode imaging alone were found to be malignant.
Five of these were found to be grade 1 liposarcomas with
normal histology but with cytogenetic analysis confirming
MDM2 amplification. The limitation of radiological assess-
ment in this particular mass is well recognised and could also
potentially produce errors in elastography analysis, as
the mass behaves grossly as a solid benign lesion [23]. Of
the other lesions, three were also low-grade sarcomas
(fibromyxoid), but one that was scored as a sebaceous cyst
on B mode imaging was a high-grade pleomorphic sarcoma.
We found that in unadjusted analyses the odds of malig-
nancy were not substantively associated with quantitative
shear wave velocity with a non-significant trend for malignant
masses to exhibit slower velocities. Longitudinal and trans-
verse shear wave velocity measurements were strongly corre-
lated. Malignancy was found to be more likely in older pa-
tients with larger lesions, necrotic lesions, and those with
disorganised internal doppler vascularity.
The qualitative component of the study demonstrated that
colour map readings correlated with the mean shear wave
velocity, with substantial reader agreement. There was a ten-
dency for malignant masses to be towards the blue spectrum
(lower velocities), which is similar to the findings ofMagarelli
et al and Park et al [16, 17]. The proportion of lesions found to
be malignant did not differ substantively between those le-
sions that where predominantly blue, cyan, or yellow, but
those with predominantly red lesions were less likely to be
malignant. Again, this finding is in keeping with Magarelli
et al.; as in their study (n = 32), our sample size is small
(n=93), but the current study had a much higher proportion
of patients with histological confirmation of diagnosis (88/93
compared to 12/32). Park et al. focused on epidermoid cysts
(n=29) showing lower strain elasticity than malignant masses
(n=20) using a subjective colour-coding system.
Elastography measurement failure rates (3.1-3.8 %) and
unreliable values (7-15.8 %) have been described in the eval-
uation of hepatic fibrosis [24, 25]. In this current study if the
lesion could be visualised on US then the shear wave velocity
readings were always obtainable. The reason for this differ-
ence is unknown but may be due to the wide velocity range
available (10 m/s), eliminating any aliasing error due to in-
creased density within or adjacent to the mass.
Limitations to this study include the relatively small popu-
lation size (n=105), but this number is larger than any previ-
ous musculoskeletal series. Although it fell short of the
intended sample size of 135, with 39 malignant lesions the
event-per-variable ratio was still approximately 10:1 in our
multivariable logistic regression models of malignancy, which
contained up to four variables. Histology was available in the
majority of patients (99/105), with the remaining patients hav-
ing clinical and imaging follow-up. All malignant lesions had
histological confirmation. Inaccuracies in the B-mode assess-
ment may have occurred due to scoring the images in isolation
without any clinical history, or previous or alternate studies
(e.g. MRI).
In conclusion, this study demonstrates that whilst there
may be some evidence of an association between lower shear
wave velocity and soft tissue malignancy, particularly in the
transverse plane, this did not result in a substantive improve-
ment in the ability to detect malignancy over B-mode consen-
sus classification. Qualitatively, the findings that colour maps
may be more suggestive of a benign pathology if they are
predominantly red and amalignancy if they are predominantly
blue (lower velocities) was not discriminatory, as all colour
groups contained benign and malignant masses. However, the
major difference to consider when comparing elastography
use in musculoskeletal soft tissue masses to thyroid and breast
lesions is the much greater variation in grade and histological
type that occur with sarcomas. Exact typing for sarcoma di-
agnosis or even its exclusion is often only made after cytoge-
netic or molecular analysis with differentiation not possible on
imaging, or gross or histological analysis. Future studies may
need to collate larger numbers of specific sarcoma sub-types
and grades to evaluate this technique in this very heteroge-
neous tumour type.
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